Bausch Health Companies Inc (NYSE:BHC)
| 5.60 Delayed Data As of Aug 05 |  +0.48 / +9.37%Today’s Change | 4.00 Today|||52-Week Range 29.59 | -79.72% Year-to-Date |
Latest BHC News | Press Releases
| Supernus Pharmaceuticals (SUPN) Q2 Earnings Lag Estimates Aug 04 / Zacks.com - Paid Partner Content | Bausch Health (BHC) Dips More Than Broader Markets: What You Should Know Aug 01 / Zacks.com - Paid Partner Content |
| Personalis (PSNL) Reports Q2 Loss, Tops Revenue Estimates Aug 03 / Zacks.com - Paid Partner Content | Bausch (BHC) Loses 39% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner Jul 29 / Zacks.com - Paid Partner Content |
| What's in the Cards for Bausch Health (BHC) Q2 Earnings? Aug 02 / Zacks.com - Paid Partner Content | Why Shares of Bausch Health Companies Dropped 54.4% This Week Jul 28 / MotleyFool.com - Paid Partner Content |
| Analysts Estimate Bausch Health (BHC) to Report a Decline in Earnings: What to Look Out for Aug 02 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 5.12 |
| Today’s open | 5.05 |
| Day’s range | 4.96 - 5.68 |
| Volume | 9,746,204 |
| Average volume (3 months) | 7,447,950 |
| Market cap | -- |
Data as of 4:03pm ET, 08/05/2022
Growth & Valuation
| Earnings growth (last year) | -67.44% |
| Earnings growth (this year) | -10.42% |
| Earnings growth (next 5 years) | +4.85% |
| Revenue growth (last year) | +5.07% |
| P/E ratio | NM |
| Price/Sales | 1.17 |
| Price/Book | -- |
Competitors
| ---- | ||
| KRYSKrystal Biotech Inc | +3.62 | +4.61% |
| ---- | ||
| --Almirall SA | 0.00 | 0.00% |
Data as of 4:03pm ET, 08/05/2022
Financials
| Next reporting date | August 9, 2022 |
| EPS forecast (this quarter) | $0.91 |
| Annual revenue (last year) | $8.4B |
| Annual profit (last year) | -$948.0M |
| Net profit margin | -11.24% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Laval, Quă©bec |
Forecasts
